Show simple item record

dc.contributor.authorHo, Jeff
dc.contributor.authorPutnam, Lauren
dc.contributor.authorSavath, Vince
dc.contributor.authorScott, Bill
dc.date.accessioned2004-11-12T17:21:56Z
dc.date.available2004-11-12T17:21:56Z
dc.date.issued2004-11-12T17:21:56Z
dc.identifier.urihttps://hdl.handle.net/1813/202
dc.descriptionNo access to the full paper due to lack of a FERPA release.
dc.description.abstractMillions of people around the world suffer from asthma, which is characterized by breathing problems due to constricting bronchioles. While current remedies involve an effective inhaler drug, such as Albuterol, that relieves such symptoms, it still has not been determined exactly how often such a drug should be administered. This project uses GAMBIT and FIDAP to model the uptake of Albuterol in bronchioles in order to determine how often these inhalers should be used to maximize drug delivery and quickly minimize symptoms. A suitable model of drug flow through the bronchioles was developed and we were able to determine how much Albuterol was present in the bronchioles at any given time. It was determined that the concentration reaches steady state at about 0.004 seconds, and concentration at every point was directly proportional to the defined inlet concentration after that. However, since we were not able to find the therapeutic concentration, or the minimum amount of Albuterol needed to be effective in relieving symptoms, we could not quite figure out the proper time spacing between inhaled dosages.
dc.format.extent47 bytes
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.relation.ispartofseries2002;1
dc.subjectalbuterol
dc.subjectbronchioles
dc.subjectasthma
dc.titleAlbuterol Uptake in Bronchiolesen_US
dc.typeterm paperen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Statistics